ATE426575T1 - Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben - Google Patents

Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben

Info

Publication number
ATE426575T1
ATE426575T1 AT04700494T AT04700494T ATE426575T1 AT E426575 T1 ATE426575 T1 AT E426575T1 AT 04700494 T AT04700494 T AT 04700494T AT 04700494 T AT04700494 T AT 04700494T AT E426575 T1 ATE426575 T1 AT E426575T1
Authority
AT
Austria
Prior art keywords
anostructures
peptide
producing
same
foreign material
Prior art date
Application number
AT04700494T
Other languages
English (en)
Inventor
Ehud Gazit
Meital Reches
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of ATE426575T1 publication Critical patent/ATE426575T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10D—INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
    • H10D30/00—Field-effect transistors [FET]
    • H10D30/60—Insulated-gate field-effect transistors [IGFET]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10D—INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
    • H10D48/00—Individual devices not covered by groups H10D1/00 - H10D44/00
    • H10D48/40—Devices controlled by magnetic fields
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Disintegrating Or Milling (AREA)
AT04700494T 2003-01-07 2004-01-07 Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben ATE426575T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43833103P 2003-01-07 2003-01-07
US45837803P 2003-03-31 2003-03-31

Publications (1)

Publication Number Publication Date
ATE426575T1 true ATE426575T1 (de) 2009-04-15

Family

ID=32717969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04700494T ATE426575T1 (de) 2003-01-07 2004-01-07 Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben

Country Status (5)

Country Link
US (4) US7504383B2 (de)
EP (2) EP1583713B1 (de)
AT (1) ATE426575T1 (de)
DE (1) DE602004020179D1 (de)
WO (1) WO2004060791A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146458B4 (de) 2000-09-21 2005-11-24 Autoliv Development Ab Gassackanordnung mit durch Anordnung von zwei Gasgeneratoren verlängerter Standzeit
EP1467868A4 (de) 2002-01-02 2009-04-01 Jemtex Ink Jet Printing Ltd Tintenstrahldruckvorrichtung
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
EP1583713B1 (de) 2003-01-07 2009-03-25 Ramot at Tel Aviv University Ltd. Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
DK1608281T3 (en) 2003-04-03 2016-10-31 Galil Medical Ltd DEVICE FOR EXACTLY LIMITED CRYOABLATION
CA2540407A1 (en) 2003-09-25 2005-03-31 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) 2003-10-02 2005-04-07 Ramot At Tel Aviv University Ltd. Novel antibacterial agents and methods of identifying and utilizing same
WO2005108302A2 (en) * 2004-03-19 2005-11-17 Research Foundation Of The City University Of New York Magnetic nanotubes
WO2006006172A2 (en) * 2004-07-15 2006-01-19 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
EP1781310B1 (de) 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Artikel von peptidnanostrukturen und herstellungsverfahren dafür
ATE539745T1 (de) 2004-08-19 2012-01-15 Univ Tel Aviv Future Tech Dev Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
WO2006027780A2 (en) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
WO2007018562A2 (en) 2004-09-22 2007-02-15 Nanolab, Inc. Nanospearing for molecular transportation into cells
US7132329B1 (en) * 2005-06-29 2006-11-07 Freescale Semiconductor, Inc. Source side injection storage device with spacer gates and method therefor
US7157345B1 (en) * 2005-06-29 2007-01-02 Freescale Semiconductor, Inc. Source side injection storage device and method therefor
WO2007018542A1 (en) * 2005-08-08 2007-02-15 The Regents Of The University Of California Local manipulation of nanostructures
KR100723384B1 (ko) * 2005-09-06 2007-05-30 삼성에스디아이 주식회사 나노와이어 전자기기소자 및 그 제조방법
US10004828B2 (en) 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
US7530032B2 (en) * 2005-10-28 2009-05-05 Hewlett-Packard Development Company, L.P. Nanowire crossbar implementations of logic gates using configurable, tunneling resistor junctions
US7879212B2 (en) 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes
FI121543B (fi) * 2005-11-17 2010-12-31 Beneq Oy Järjestely ALD-reaktorin yhteydessä
CN101652382B (zh) * 2006-12-04 2016-04-06 特拉维夫大学拉莫特有限公司 有机纳米结构阵列的形成
US20080173652A1 (en) * 2007-01-23 2008-07-24 Bob Chou Integral heat-resisting structure of a disposable drinking cup
WO2008106732A1 (en) * 2007-03-05 2008-09-12 Commonwealth Scientifc And Industrial Research Organisation Thermoelectric material
EP2145348A1 (de) * 2007-05-01 2010-01-20 Romny Scientific, Inc. Verfahren zur herstellung einer thermoelektrischen voprrichtung aus partikelförmigem rohmaterial
GB2462108A (en) * 2008-07-24 2010-01-27 Sharp Kk Deposition of a thin film on a nanostructured surface
EP2344913B1 (de) * 2008-10-02 2015-02-18 Ramot at Tel-Aviv University Ltd. Verfahren und system zur lichtemission
US8470409B2 (en) * 2009-04-28 2013-06-25 Ben Gurion University Of The Negev Research And Development Authority Nanowires, method of fabrication the same and uses thereof
WO2011031999A2 (en) * 2009-09-10 2011-03-17 Purdue Research Foundation Multi-component nanoparticle structure having detectable magnetic resonance properties
US8415859B2 (en) * 2009-10-27 2013-04-09 Korea University Research And Business Foundation Piezoelectric nanodevices
US8917018B2 (en) * 2010-01-19 2014-12-23 Ramot At Tel-Aviv University Ltd. Nanomatrix separation of chromophores and uses thereof in luminescent devices
EP2575909B1 (de) 2010-06-03 2020-01-15 Technology Innovation Momentum Fund (Israel) Limited Partnership Verformbare hydrogelhybride aus selbstangeordneten peptiden und biokompatiblen polymeren sowie ihre verwendung
WO2012095811A1 (en) * 2011-01-13 2012-07-19 Ramot At Tel-Aviv University Ltd. Charge storage organic memory system
KR101754282B1 (ko) * 2011-03-30 2017-07-06 한국전자통신연구원 터널링 소자 및 그의 제조방법
US10303842B2 (en) * 2012-12-10 2019-05-28 Hercules Llc Device for sensorial evaluation of consumer product application feel
CN104109909B (zh) 2013-04-18 2018-09-04 财团法人工业技术研究院 纳米金属线材与其制作方法
KR20160003274A (ko) 2013-05-02 2016-01-08 테크놀로지 이노베이션 모멘텀 펀드 (이스라엘) 리미티드 파트너쉽 자기-조립 펩티드 핵산
US20160115196A1 (en) * 2013-05-28 2016-04-28 Ramot At Tel-Aviv University Ltd. Self-assembled micro-and nanostructures
EP3186272A4 (de) 2014-08-25 2018-02-21 The Governors Of The University Of Alberta Funktionalisierte durch beta-faltblattpeptid stabilisierte membranproteine, konstrukte damit und verfahren zur formung und verwendung davon
US9970297B2 (en) * 2014-08-29 2018-05-15 Rolls-Royce Corporation Composite fan slider with nano-coating
US9790254B2 (en) 2015-05-10 2017-10-17 Ramot At Tel-Aviv University Ltd. Self-assembled peptide nanostructures
WO2017024017A1 (en) * 2015-08-06 2017-02-09 Pacific Biosciences Of California, Inc. Systems and methods for selectively addressing sparsely arranged electronic measurement devices
WO2018006010A1 (en) * 2016-06-30 2018-01-04 The University Of North Carolina At Chapel Hill Methods and systems for welding of semiconductor nanowires
US12123018B2 (en) 2017-07-13 2024-10-22 Ramot At Tel-Aviv University Ltd. Self-assembled hybrid hydrogels formed of a short aromatic peptide and an aromatic amino acid
EP3948272A4 (de) 2019-03-25 2023-03-15 Ramot at Tel-Aviv University Ltd. Piezoelektrische materialien auf peptidbasis und diese enthaltende piezoelektrische vorrichtungen
US11437570B2 (en) * 2019-08-16 2022-09-06 Yonsei University, University—Industry Foundation (UIF) Resistive switching memory device based on multi-inputs
CN110699734B (zh) * 2019-10-30 2021-09-07 金力永磁(包头)科技有限公司 一种钕铁硼磁体的电泳挂具和电泳工件上料及下料装置
TWI735393B (zh) * 2020-12-10 2021-08-01 苗新元 能源採集裝置

Family Cites Families (180)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2920080A (en) * 1960-01-05 Process of preparing tryptamine
US3042685A (en) * 1962-07-03 Process of making g-fluoro tryptamine
BE638366A (de) 1963-10-09
FR1540484A (fr) * 1967-08-17 1968-09-27 Pasteur Institut Préparation de dérivés oxygénés de l'indole
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3976639A (en) * 1970-11-04 1976-08-24 Hoffmann-La Roche Inc. Intermediates for indoles
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3790596A (en) * 1971-05-14 1974-02-05 V Shkilkova Method of producing indole and substitution products of the same
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
PH14917A (en) 1978-10-23 1982-01-29 Abbott Lab Anti-bacterial peptide
DE2905531A1 (de) * 1979-02-14 1981-01-08 Boehringer Mannheim Gmbh Diagnostisches mittel zum nachweis von leukozyten in koerperfluessigkeiten
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
DE3233679A1 (de) 1981-12-08 1984-03-08 Wilhelm Dr.med. 8900 Augsburg Meyer-Glauner Carrier-tripeptid mit antifungischer wirksamkeit
JPS5944313A (ja) 1982-09-07 1984-03-12 Yakult Honsha Co Ltd 抗菌性組成物
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6040061A (ja) 1983-08-12 1985-03-02 ユニチカ株式会社 抗菌剤徐放性導尿カテ−テル
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
DE3412445C2 (de) 1984-03-31 1986-10-30 Wilhelm Dr. 7400 Tübingen Meyer-Glauner Tripeptid und dieses enthaltende antifungische Mittel
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
JPS61253065A (ja) 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
DE122007000007I1 (de) 1986-04-09 2007-05-16 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
JPS6344895A (ja) 1986-08-13 1988-02-25 Kyowa Hakko Kogyo Co Ltd 抗アミロイドａ蛋白質単クロ−ン性抗体
NL8720442A (nl) * 1986-08-18 1989-04-03 Clinical Technologies Ass Afgeefsystemen voor farmacologische agentia.
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US4970233A (en) * 1987-08-04 1990-11-13 Mchugh John E Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/LAV infections and Acquired Immunodeficiency Syndroms (AIDS) Related Complex (ARC)
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
JPH02295923A (ja) 1989-05-10 1990-12-06 Taiyo Kagaku Co Ltd 腸内クロストリジウム属細菌の増殖阻害剤
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
IT1237472B (it) * 1989-10-04 1993-06-07 Polifarma Spa Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
DK0494955T3 (da) * 1989-10-05 1998-10-26 Optein Inc Cellefri syntese og isolering af hidtil ukendte gener og polypeptider
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5637459A (en) * 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US5683867A (en) * 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5496938A (en) * 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5567588A (en) * 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
CA2084987C (en) * 1990-06-11 2007-02-13 Gilead Sciences, Inc. Nucleic acid ligands
US5705337A (en) * 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ES2108048T3 (es) * 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
US5171505A (en) 1990-11-28 1992-12-15 E. I. Du Pont De Nemours And Company Process for spinning polypeptide fibers
JP2919142B2 (ja) * 1990-12-27 1999-07-12 株式会社東芝 感光性組成物およびそれを用いたパターン形成方法
DE4101895C1 (de) * 1991-01-23 1991-12-05 Forschungszentrum Juelich Gmbh, 5170 Juelich, De
AU1879892A (en) 1991-04-24 1992-12-21 Warner-Lambert Company Cck analogs containing alpha-substituted amino acids
US5856928A (en) 1992-03-13 1999-01-05 Yan; Johnson F. Gene and protein representation, characterization and interpretation process
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
WO1994005311A1 (en) * 1992-08-27 1994-03-17 Deakin Research Limited Retro-, inverso-, and retro-inverso synthetic peptide analogues
EP0710228B1 (de) * 1993-07-19 1998-01-21 Resolution Pharmaceuticals Inc. Hydrazine mit einer n3s konfiguration als radionukleide chelatoren
DK0723554T3 (da) * 1993-10-14 2004-02-02 Scripps Research Inst Cyklisk peptidrør
US5581091A (en) 1994-12-01 1996-12-03 Moskovits; Martin Nanoelectric devices
US5807718A (en) * 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
US6303567B1 (en) * 1995-03-14 2001-10-16 Praecis Pharmaceuticals, Inc . Modulators of β-amyloid peptide aggregation comprising D-amino acids
US6162828A (en) * 1995-03-31 2000-12-19 Takeda Chemical Industries, Ltd. Cysteine protease inhibitor
ES2160827T3 (es) * 1995-07-11 2001-11-16 Degussa Procedimiento para la preparacion de peptidos y peptidos n-carbamoil protegidos.
AU7456396A (en) 1995-11-02 1997-05-22 Warner-Lambert Company Inhibition of amyloidosis by 9-acridinones
WO1997019208A1 (en) 1995-11-22 1997-05-29 Northwestern University Method of encapsulating a material in a carbon nanotube
US5688561A (en) 1996-04-16 1997-11-18 Kabushiki Kaisha Nippankenkyusho Coating method
US6255286B1 (en) * 1996-06-25 2001-07-03 Nisshin Flour Milling Co., Ltd. Depsipeptides and drugs containing the same as the active ingredient
US6721083B2 (en) 1996-07-19 2004-04-13 E Ink Corporation Electrophoretic displays using nanoparticles
US6610478B1 (en) * 1996-08-16 2003-08-26 Yale University Phenotypic conversion of cells mediated by external guide sequences
US6617114B1 (en) * 1996-10-31 2003-09-09 Karo Bio Ab Identification of drug complementary combinatorial libraries
US6426075B1 (en) 1996-11-06 2002-07-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protease-activatable pseudomonas exotoxin A-like proproteins
DE19646505A1 (de) * 1996-11-12 1998-05-14 Itt Ind Gmbh Deutsche Vorrichtung zur Durchführung von Untersuchungen an Zellproben und dergleichen
JPH10245342A (ja) 1997-03-03 1998-09-14 Mitsui Norin Kk β−アミロイド蛋白の神経細胞毒性低減剤
US20020086847A1 (en) * 1997-04-09 2002-07-04 Mindset Biopharmaceuticals (Usa) Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
DE19725619A1 (de) 1997-06-17 1998-12-24 Fraunhofer Ges Forschung Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien
JP3740295B2 (ja) 1997-10-30 2006-02-01 キヤノン株式会社 カーボンナノチューブデバイス、その製造方法及び電子放出素子
US5977302A (en) 1997-11-20 1999-11-02 Ortho-Mcneil Pharmaceutical, Inc. Liquid phase process for the preparation of GnRH peptides
EA005244B1 (ru) 1998-02-23 2004-12-30 Саут Алабама Медикал Сайенс Фаундейшн Индол-3-пропионовые кислоты, их соли и эфиры, используемые в качестве лекарств
US6428811B1 (en) 1998-03-11 2002-08-06 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
US6110590A (en) * 1998-04-15 2000-08-29 The University Of Akron Synthetically spun silk nanofibers and a process for making the same
US6277870B1 (en) 1998-05-04 2001-08-21 Astra Ab Use
EP1075512B1 (de) 1998-05-07 2010-04-14 Universite Libre De Bruxelles Auf cytotoxinen basierendes biologisches einschlusssystem
JP3340699B2 (ja) 1998-06-05 2002-11-05 東京瓦斯株式会社 膵外分泌機能診断剤
US6426134B1 (en) 1998-06-30 2002-07-30 E. I. Du Pont De Nemours And Company Single-wall carbon nanotube-polymer composites
US6172902B1 (en) 1998-08-12 2001-01-09 Ecole Polytechnique Federale De Lausanne (Epfl) Non-volatile magnetic random access memory
US6602469B1 (en) 1998-11-09 2003-08-05 Lifestream Technologies, Inc. Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system
WO2000030683A1 (en) 1998-11-19 2000-06-02 Shionogi & C0., Ltd. Preventives and/or remedies for central nervous system diseases containing compounds having txa2 receptor antagonism and/or txa2 synthase inhibitory effect
JP2000193661A (ja) 1998-12-25 2000-07-14 Tokyo Rika Kikai Kk 痴呆症の検査方法
AU5646800A (en) * 1999-03-02 2000-09-21 Helix Biopharma Corporation Card-based biosensor device
US6559468B1 (en) 1999-03-29 2003-05-06 Hewlett-Packard Development Company Lp Molecular wire transistor (MWT)
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
US6361861B2 (en) 1999-06-14 2002-03-26 Battelle Memorial Institute Carbon nanotubes on a substrate
US6504292B1 (en) 1999-07-15 2003-01-07 Agere Systems Inc. Field emitting device comprising metallized nanostructures and method for making the same
JP2003506411A (ja) 1999-08-09 2003-02-18 トリペップ アクチ ボラゲット タンパク質重合阻害剤および使用方法
GB9922013D0 (en) * 1999-09-17 1999-11-17 Univ Sussex Peptides
US6340822B1 (en) 1999-10-05 2002-01-22 Agere Systems Guardian Corp. Article comprising vertically nano-interconnected circuit devices and method for making the same
US6689753B1 (en) * 1999-11-05 2004-02-10 Axonyx, Inc. β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide
US6677153B2 (en) * 1999-11-29 2004-01-13 Avi Biopharma, Inc. Antisense antibacterial method and composition
WO2001045726A2 (en) 1999-12-21 2001-06-28 Mars, Incorporated The use of procyanidins in the modulation of cytokine gene expression and protein secretion
JP2003519192A (ja) * 1999-12-30 2003-06-17 プロテオテック・インコーポレーテッド アルツハイマー病におけるアミロイド症および他のアミロイド症の治療のためのカテキンおよび緑茶抽出物
US20010047032A1 (en) 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
US6560077B2 (en) 2000-01-10 2003-05-06 The University Of Alabama CPP spin-valve device
US6530944B2 (en) 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US20010029830A1 (en) * 2000-02-28 2001-10-18 Rosen Daniel Ira Device and method for testing music proficiency
US20020006954A1 (en) * 2000-03-02 2002-01-17 Oklahoma Medical Research Foundation Desmethyl tocopherols for preventing or slowing degenerative neurological diseases
JP2003535832A (ja) 2000-06-09 2003-12-02 ブリカス，テニ ポリヌクレオチドおよび薬物の標的化リポソームへのカプセル化
US6472436B1 (en) * 2000-07-17 2002-10-29 The Salk Institute For Biological Studies Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
US20040152672A1 (en) * 2000-08-09 2004-08-05 Carson Dennis A. Indole compounds useful for the treatment of cancer
US7301199B2 (en) 2000-08-22 2007-11-27 President And Fellows Of Harvard College Nanoscale wires and related devices
DE10043282A1 (de) 2000-09-02 2002-03-28 Kurt Heininger Verwendung von Inhibitoren der Amyloid-beta-Protein-Bildung
US6949216B2 (en) 2000-11-03 2005-09-27 Lockheed Martin Corporation Rapid manufacturing of carbon nanotube composite structures
US20020151506A1 (en) * 2000-12-29 2002-10-17 Castillo Gerardo M. Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
US6586095B2 (en) 2001-01-12 2003-07-01 Georgia Tech Research Corp. Semiconducting oxide nanostructures
JP3560333B2 (ja) * 2001-03-08 2004-09-02 独立行政法人 科学技術振興機構 金属ナノワイヤー及びその製造方法
ITVR20010031A1 (it) 2001-03-12 2002-09-12 Hisanori Suzuki Uso di epigallocatechin-3-gallato o suoi derivati nella profilassi e nel trattamento delle malattie neurodegenerative.
ES2387910T3 (es) 2001-03-15 2012-10-03 Proteotech Inc. Catequinas para el tratamiento de la fibrilogénesis en la enfermedad de Alzheimer, la enfermedad de Parkinson, la amiloidosis sistémica AA y otros trastornos amiloides
AU2002254328A1 (en) * 2001-03-20 2002-10-03 University Of Chicago Inhibitors and disassemblers of fibrillogenesis
US6986853B2 (en) 2001-03-26 2006-01-17 Eikos, Inc. Carbon nanotube fiber-reinforced composite structures for EM and lightning strike protection
US6902720B2 (en) * 2001-05-10 2005-06-07 Worcester Polytechnic Institute Cyclic peptide structures for molecular scale electronic and photonic devices
WO2002093140A1 (en) 2001-05-14 2002-11-21 Johns Hopkins University Multifunctional magnetic nanowires
US6670539B2 (en) 2001-05-16 2003-12-30 Delphi Technologies, Inc. Enhanced thermoelectric power in bismuth nanocomposites
WO2002094857A1 (en) 2001-05-23 2002-11-28 The Curators Of The University Of Missouri Inverse solid phase synthesis of peptides
US6750604B2 (en) 2001-05-23 2004-06-15 Industrial Technology Research Institute Field emission display panels incorporating cathodes having narrow nanotube emitters formed on dielectric layers
KR100439579B1 (ko) * 2001-06-07 2004-07-12 학교법인 포항공과대학교 유기 나노관의 합성 및 이를 주형으로 이용한 초미세 금속나노선의 합성
US6432740B1 (en) 2001-06-28 2002-08-13 Hewlett-Packard Company Fabrication of molecular electronic circuit by imprinting
US6574130B2 (en) 2001-07-25 2003-06-03 Nantero, Inc. Hybrid circuit having nanotube electromechanical memory
RU2196568C1 (ru) 2001-08-08 2003-01-20 Киселев Всеволод Иванович Фармацевтическая композиция для профилактики и лечения дисплазий и рака шейки матки и папилломатоза гортани, а также способ профилактики и лечения этих заболеваний на ее основе
CA2357053A1 (en) * 2001-09-04 2003-03-04 Unknown Effectiveness of a combination of antioxidant substances for the treatment of alzheimer's disease
US6620850B2 (en) 2001-09-19 2003-09-16 University Of Florida Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US6976639B2 (en) * 2001-10-29 2005-12-20 Edc Biosystems, Inc. Apparatus and method for droplet steering
WO2003039540A2 (en) 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US6882767B2 (en) 2001-12-27 2005-04-19 The Regents Of The University Of California Nanowire optoelectric switching device and method
US6905586B2 (en) 2002-01-28 2005-06-14 Ut-Battelle, Llc DNA and RNA sequencing by nanoscale reading through programmable electrophoresis and nanoelectrode-gated tunneling and dielectric detection
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
JP2006506942A (ja) 2002-01-31 2006-03-02 テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
US20050020809A1 (en) * 2002-01-31 2005-01-27 Ehud Gazit Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
TW200307563A (en) 2002-02-14 2003-12-16 Sixty Inc C Use of BUCKYSOME or carbon nanotube for drug delivery
AU2003215280A1 (en) * 2002-02-15 2003-09-09 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
DE10206723A1 (de) 2002-02-18 2003-09-04 Ulrich Schraermeyer Therapie von Erkrankungen des Auges und des Zentralen Nervensystems
WO2003077866A2 (en) 2002-03-14 2003-09-25 Ash Access Technology, Inc. Medical devices exhibiting antibacterial properties
JP3522261B2 (ja) 2002-04-18 2004-04-26 日本電気株式会社 ナノチューブ、近接場光検出装置および近接場光検出方法
US20050124535A1 (en) * 2002-05-10 2005-06-09 Mcgimpsey William G. Cyclic peptide nanotube structures for molecular scale electronic and photonic devices
US6803379B2 (en) * 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
AU2002950217A0 (en) * 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
US20040029830A1 (en) * 2002-08-06 2004-02-12 Hebert Rolland F. Water-soluble indole-3-propionic acid
US20040116969A1 (en) 2002-08-26 2004-06-17 Owen James M. Pulse detection using patient physiological signals
ATE509886T1 (de) * 2002-12-09 2011-06-15 Univ Ramot Peptidnanostrukturen, verfahren zu deren herstellung und verwendung
US7491699B2 (en) * 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
EP1583713B1 (de) 2003-01-07 2009-03-25 Ramot at Tel Aviv University Ltd. Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
AU2004210853A1 (en) 2003-02-11 2004-08-26 Northwestern University Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
CA2530927A1 (en) * 2003-06-30 2005-01-06 Tel Aviv University Future Technology Development L.P. Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
WO2005016339A1 (en) 2003-07-24 2005-02-24 Case Western Reserve University Methods for the treatment of parkinson's disease
US7348399B2 (en) * 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
CA2540407A1 (en) 2003-09-25 2005-03-31 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) 2003-10-02 2005-04-07 Ramot At Tel Aviv University Ltd. Novel antibacterial agents and methods of identifying and utilizing same
EP1781310B1 (de) * 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Artikel von peptidnanostrukturen und herstellungsverfahren dafür
ATE539745T1 (de) * 2004-08-19 2012-01-15 Univ Tel Aviv Future Tech Dev Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
WO2006027780A2 (en) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
JP4448949B2 (ja) 2004-10-22 2010-04-14 パナソニック株式会社 導電性ペプチドナノファイバー及びその製造方法
AU2006251832A1 (en) 2005-05-27 2006-11-30 Queen's University At Kingston Treatment of protein folding disorders
GB0518220D0 (en) 2005-09-07 2005-10-19 Univ Manchester Method of preparing a hydrogel
US8420605B2 (en) 2005-09-07 2013-04-16 The University Of Strathclyde Hydrogel compositions
WO2007035405A2 (en) 2005-09-16 2007-03-29 University Of Pittsburgh In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein
US10004828B2 (en) * 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
US7879212B2 (en) * 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes

Also Published As

Publication number Publication date
WO2004060791A1 (en) 2004-07-22
US20130075703A1 (en) 2013-03-28
EP1583713A1 (de) 2005-10-12
EP2058275A1 (de) 2009-05-13
US7504383B2 (en) 2009-03-17
DE602004020179D1 (de) 2009-05-07
US20060079455A1 (en) 2006-04-13
US20090121709A1 (en) 2009-05-14
US8501697B2 (en) 2013-08-06
EP1583713B1 (de) 2009-03-25
US8017586B2 (en) 2011-09-13
US20110266517A1 (en) 2011-11-03
US8314069B2 (en) 2012-11-20

Similar Documents

Publication Publication Date Title
ATE426575T1 (de) Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
DE60329298D1 (de) Polymerisierbare zusammensetzung, die zusammensetzung enthaltendes optisches material und verfahren zur herstellung des materials
DE502004009597D1 (de) Gummimaterial und verfahren zur herstellung desselben
DE60122533D1 (de) Kolben und verfahren zur herstellung
ATE520780T1 (de) Pflanzen mit veränderten wachstumseigenschaften und verfahren zur deren herstellung
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE60332268D1 (de) Druckbehälter und verfahren zur herstellung des druckbehälters
DE60231548D1 (de) N; formkörper und verfahren zu ihrer herstellung
ATE304062T1 (de) Vollnarbiges rindnappaleder und verfahren zur herstellung desselben
DE60143489D1 (de) Schwefel-enthaltende düngelmittelzusammensetzung und verfahren zur herstellung derselben
DE60110044D1 (de) Teilentwässertes umsetzungsprodukt, verfahren zur herstellung desselben, und dasselbe enthaltende emulsion
DE60331745D1 (de) Biologisch abbaubares harz, biologisch abbaubare harzzusammensetzung, biologisch abbaubarer formkörper und verfahren zur herstellung von biologisch abbaubarem harz
DE602004020538D1 (de) Verfahren und Vorrichtung zur Laserbestrahlung, sowie Verfahren zur Herstellung von Halbleiter.
DE60217366D1 (de) Sphärischer bandförmiger dichtungskörper und verfahren zur herstellung des dichtungskörpers
ATE390300T1 (de) Luftreifen und verfahren für seine herstellung
DE60236814D1 (de) 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung
DE60213444D1 (de) Fluorpolymerlaminate und verfahren zur herstellung derselben
ATA18032003A (de) Aluminiumlegierung, bauteil aus dieser und verfahren zur herstellung des bauteiles
DE60201390D1 (de) Kondensatormikrofon und Verfahren zur dessen Herstellung
ATE396180T1 (de) Verfahren zur herstellung von 2,6-diamino-4,5,6,7-tetrahydrobenzothiazol
ATE465990T1 (de) Arylalkylcarbamatderivate, verfahren zur ihrer herstellung und deren therapeutischen anwendungen
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60333840D1 (de) Geformte absorbierende auflagen und verfahren zur dessen herstellung
DE60235032D1 (de) Rkörpers und verfahren zur herstellung des werkzeugs
DE60214035D1 (de) Olefinisches thermoplastisches elastomer, verfahren zu seiner herstellung, olefinisches thermoplastisches elastomer enthaltende zusammensetzungen, verfahren zu ihrer herstellung und formkörper daraus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties